Cargando…
PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer
BACKGROUND: Triple negative breast cancer affects 10% to 20% of all women diagnosed with breast cancer. Due to its characteristics, treatment strategies are limited and metastatic recurrences are common in the first 5 years after treatment. However, not all patients affected by this disease develop...
Autores principales: | Lusho, Sejdi, Durando, Xavier, Bidet, Yannick, Molnar, Ioana, Kossai, Myriam, Bernadach, Maureen, Lacrampe, Nathalie, Veyssiere, Hugo, Cavaille, Mathias, Gay-Bellile, Mathilde, Radosevic-Robin, Nina, Abrial, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738079/ https://www.ncbi.nlm.nih.gov/pubmed/33327268 http://dx.doi.org/10.1097/MD.0000000000023418 |
Ejemplares similares
-
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer
por: Veyssière, Hugo, et al.
Publicado: (2021) -
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2021) -
Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
por: Lusho, Sejdi, et al.
Publicado: (2021) -
Sister Mary Joseph Nodules: A Case Report about a Rare Location of Skin Metastasis
por: Leyrat, Brice, et al.
Publicado: (2021) -
Case Series of 11 CDH1 Families (47 Carriers) Including Incidental Findings, Signet Ring Cell Colon Cancer and Review of the Literature
por: Lepage, Mathis, et al.
Publicado: (2023)